We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

147 hedge funds and large institutions have $1.38B invested in NxStage Medical Inc. in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,116% more call options, than puts

Call options by funds: $997K | Put options by funds: $82K

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

51% more capital invested

Capital invested by funds: $913M → $1.38B (+$466M)

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

5% more funds holding

Funds holding: 140 → 147 (+7)

22% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 55

Holders
147
Holders Change
+7
Holders Change %
+5%
% of All Funds
3.92%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.21%
New
27
Increased
43
Reduced
55
Closed
20
Calls
$997K
Puts
$82K
Net Calls
+$915K
Net Calls Change
-$774K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$54.2M
2
PA
Perceptive Advisors
New York
+$24.7M
3
CCM
Consonance Capital Management
New York
+$14.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$8.54M
5
PC
Polar Capital
United Kingdom
+$6.69M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$18.3M
2
DM
Deerfield Management
New York
-$17.9M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$9.67M
4
TA
Tamarack Advisers
California
-$8.92M
5
CCM
Cadian Capital Management
New York
-$7.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
151
Algert Global
California
– -$500K -33,346 Closed
NI
152
Numeric Investors
Massachusetts
– -$441K -29,400 Closed
ECM
153
Endurant Capital Management
California
– -$396K -26,400 Closed
TI
154
Trexquant Investment
Connecticut
– -$382K -25,500 Closed
Calamos Advisors
155
Calamos Advisors
Illinois
– -$323K -21,550 Closed
Nomura Holdings
156
Nomura Holdings
Japan
– -$308K -20,547 Closed
SCA
157
Secor Capital Advisors
New York
– -$188K -12,569 Closed
SCM
158
Stevens Capital Management
Pennsylvania
– -$174K -11,595 Closed
PAM
159
Princeton Alpha Management
New Jersey
– -$158K -10,541 Closed
DIA
160
Denver Investment Advisors
Colorado
– -$153K -10,190 Closed
AAP
161
Ardsley Advisory Partners
Connecticut
– -$150K -10,000 Closed
TDC
162
Thompson Davis & Co
Virginia
– -$133K -8,875 Closed
QT
163
Quantbot Technologies
New York
– -$112K -7,494 Closed
CSS
164
Cubist Systematic Strategies
Connecticut
– -$93K -6,223 Closed
HNB
165
Huntington National Bank
Ohio
– -$22K -1,250 Closed
GT
166
Glenmede Trust
Pennsylvania
– -$2.94K -165 -99%
3 4 5 6
7

NXTM Hedge Fund Activity: Q2 2016 in Review

147 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2016, worth a combined $1.38B — up 51% from $913M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new NXTM positions and 20 closed out — a net gain of 7 holders — while 43 added to existing stakes and 55 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $54.2M. The largest seller was RS Investment Management, cutting an estimated $18.3M.

  • 147 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2016, up from 140 in Q1 2016.
  • Funds reported $1.38B of NxStage Medical Inc. stock for Q2 2016, up 51% quarter-over-quarter.
  • 27 funds opened new NxStage Medical Inc. positions in Q2 2016 and 20 closed out, a net change of +7 holders.
  • The largest NxStage Medical Inc. buyer in Q2 2016 was Fidelity Investments, an estimated $54.2M added.
  • The largest NxStage Medical Inc. seller in Q2 2016 was RS Investment Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q2 2016.